How Gene Editing Therapies Could Go Beyond Rare Diseases
In the wake of the first CRISPR medicine, scientists are working to develop gene editing therapies for diseases like cystic fibrosis, ALS and cardiovascular disease.
Stay updated with breaking news from Brianc Thomas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In the wake of the first CRISPR medicine, scientists are working to develop gene editing therapies for diseases like cystic fibrosis, ALS and cardiovascular disease.
Demonstrated nonhuman primate proof of concept in Hemophilia A program; progressing towards Development Candidate nomination by mid-year; 12-month nonhuman primate durability data in 2H 2024 Proof of...
Demonstrated nonhuman primate proof of concept in Hemophilia A program; progressing towards Development Candidate nomination by mid-year; 12-month nonhuman...
EMERYVILLE, Calif., Feb. 29, 2024 -- Metagenomi, Inc. , a precision genetic medicines company committed to developing curative therapeutics for patients using its...
Collaboration with a leader in gene editing systems is Ionis' latest move to expand and diversify its technology CRISPR-Cas gene editing is a natural extension of Ionis' innovative approach to... | November 14, 2022